STOCK TITAN

Accelevation Announces Pricing of Initial Public Offering

Selling stockholders affiliated with Olympus Partners account for 20,000,000 of the offering’s 30,000,000 shares.

(Very High)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Tags

Accelevation Holdings (ACCV) priced its initial public offering of 30,000,000 Class A common shares, comprising company shares and selling-stockholder shares.

The price is $18.00 per share, with 10,000,000 shares offered by Accelevation and 20,000,000 by selling stockholders affiliated with Olympus Partners. Those stockholders granted underwriters a 30-day option to buy up to 4,500,000 additional shares. Accelevation receives no proceeds from selling-stockholder sales.

Trading on the Nasdaq Global Select Market is expected September 30, 2026; closing is expected October 1, subject to customary conditions. Accelevation intends to buy newly issued units in Accelevation Holdings LLC, which intends to use the balance of proceeds for debt repayment, offering and organizational expenses, and general corporate purposes.

Loading...
Loading translation...
2 points · 1 major

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

1 major · 3 points

Hollow bars mark forward-looking points. How the balance works

Positive

  • Major point. Forward-looking: it has not happened yet and may not happen.Accelevation’s offering of 10,000,000 shares at $18.00 each provides company funding.
  • Minor point. Forward-looking: it has not happened yet and may not happen.Accelevation Holdings LLC intends to use offering proceeds to repay indebtedness.

Negative

  • Major point. Forward-looking: it has not happened yet and may not happen.Issuance of 10,000,000 new Class A shares at $18.00 each dilutes existing holders.
  • Minor pointSales of 20,000,000 selling-stockholder shares provide no proceeds to Accelevation.
  • Minor point. Forward-looking: it has not happened yet and may not happen.Proceeds are intended partly to pay offering and organizational transaction expenses.

News Explained

If issued, Accelevation’s 10 million-share portion adds shares and reduces existing holders’ percentage ownership; the separate 20 million shares are being sold by stockholders, not issued by Accelevation.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google

MIAMISBURG, Ohio, Sept. 29, 2026 (GLOBE NEWSWIRE) -- Accelevation Holdings Corp. (“Accelevation”) today announced the pricing of its initial public offering of 30,000,000 shares of its Class A common stock at a public offering price of $18.00 per share, including 10,000,000 shares offered by Accelevation and 20,000,000 shares offered by certain selling stockholders affiliated with Olympus Partners. In addition, the selling stockholders have granted the underwriters a 30-day option to purchase up to an additional 4,500,000 shares of Class A common stock at the initial public offering price, less underwriting discounts and commissions.

The shares of Class A common stock are expected to begin trading on The Nasdaq Global Select Market on September 30, 2026 under the ticker symbol “ACCV.” The offering is expected to close on October 1, 2026, subject to customary closing conditions.

Accelevation intends to use the net proceeds from the offering to purchase newly issued units in Accelevation Holdings LLC. In turn, Accelevation Holdings LLC intends to apply the balance of the net proceeds it receives from Accelevation to repay indebtedness, pay expenses incurred in connection with the offering and certain organizational transactions and for general corporate purposes. Accelevation will not receive any of the proceeds from the sale of shares of Class A common stock by the selling stockholders.

Morgan Stanley and J.P. Morgan are acting as joint lead bookrunning managers for the proposed offering. Goldman Sachs & Co. LLC, Barclays and BofA Securities are acting as joint bookrunning managers. Houlihan Lokey, Baird, William Blair, Piper Sandler and Wolfe | Nomura Alliance are acting as additional bookrunners.

The initial public offering is being made only by means of a prospectus. Copies of the final prospectus relating to the offering, when available, may be obtained for free by visiting EDGAR on the SEC’s website at www.sec.gov. Alternatively, copies of the final prospectus may be obtained from: Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, Second Floor, New York, NY 10014; or J.P. Morgan Securities LLC, c/o Broadridge Financial Solutions, 1155 Long Island Avenue, Edgewood, NY 11717, or by email at prospectus-eq_fi@jpmchase.com.

A registration statement relating to the securities sold in the initial public offering has been filed with, and declared effective by, the U.S. Securities and Exchange Commission. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation, or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction.

About Accelevation

Accelevation is a leading designer, manufacturer and installer of customized structural, electrical and mechanical systems for mission-critical infrastructure. Its vertically integrated model combines U.S.-based manufacturing and nationwide field service capabilities to move customers faster from design through deployment with innovative, factory-built solutions engineered for speed, scalability and certainty. Accelevation solves complex needs at scale while investing in its communities, growing the skilled trades and creating opportunities for people to build lasting careers and share in the value they create. Accelevation’s principal executive offices are located at 9555 N. Springboro Pike, Suite 400, Miamisburg, Ohio 45342, and its telephone number is (937) 258-0616.

About Olympus Partners

Olympus Partners is a private equity firm focused on providing equity capital for middle market management buyouts and for growing companies. Olympus manages in excess of $12 billion mainly on behalf of pension funds, endowment funds and state-sponsored retirement programs. Founded in 1988, Olympus is an active, long-term investor across a broad range of industries including industrial and business services, food services, healthcare services, financial services, consumer and manufacturing.

For further information:

Investor Relations Contact:
Larry De Maria
ir@accelevation.com
+1 (937) 560-1133

Media Contact:
Chandler Martin
media@accelevation.com
+1 (937) 802-2931


FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What is the price and size of Accelevation’s IPO?

Accelevation’s IPO comprises 30,000,000 Class A common shares at $18.00 per share. Accelevation is offering 10,000,000 shares, while selling stockholders affiliated with Olympus Partners are offering 20,000,000. The selling stockholders also granted underwriters a 30-day option to purchase up to 4,500,000 additional shares at the IPO price, less underwriting discounts and commissions.

When will Accelevation stock begin trading and its IPO close?

Accelevation expects its Class A shares to begin trading on the Nasdaq Global Select Market on September 30, 2026, under ACCV. The offering is expected to close on October 1, 2026, subject to customary closing conditions.

Keep reading